*by Jacqueline Anastassiades Cyprus is at the start of a very difficult era for its economy, with a multitude of negative consequences on a number of aspects of everyday life. The state, but also the private sector, is trying to put the economy back on a course of...
The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) welcomes the decision to operate the Medical School at the University of Cyprus come September and is pleased that the various obstacles have been overcome. KEFEA also congratulates...
In response to reports claiming companies are not providing medication on credit as a result of the unfavourable for our country developments in the economy, the Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) assures consumers that the...
Mr Daan Gijbels, of Dutch descent and Area General Manager for GlaxoSmithKline (Cyprus), is the new president of the Cyprus Association of Research & Development Pharmaceutical Companies (KEFEA). He took over from Jacqueline Anastassiades, General Manager of Merck...
*By Petros Mavrogenis We have recently been observing the difficulties and challenges faced by many European states. Cutting costs is imperative. Today, more than ever, we must not view costs as mere expenditures but more as an investment, which will bring long term...
